CASI Pharmaceuticals, Inc. (CASI)
0.8611
-0.07
(-7.41%)
USD |
NASDAQ |
Dec 09, 15:01
CASI Pharmaceuticals Profit Margin (Quarterly): -353.9% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | -86.15% |
| Zai Lab Ltd. | -30.98% |
| Adagene, Inc. | -- |
| Adlai Nortye Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -112.9% |
| Return on Invested Capital | -405.3% |
| Gross Profit Margin (Quarterly) | 22.96% |
| Operating Margin (Quarterly) | -333.1% |
| Return on Net Operating Assets | -195.2% |